- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Clinical and Potency Studies Presented at Tandem
MSB
mesoblast limited
Add to My Watchlist
2.85%
!
$2.35

Ann: Remestemcel Clinical and Potency Studies Presented at Tandem, page-2
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.35 |
Change
0.065(2.85%) |
Mkt cap ! $2.995B |
Open | High | Low | Value | Volume |
$2.31 | $2.39 | $2.30 | $6.478M | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
38 | 61409 | $2.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.35 | 50812 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 61089 | 2.340 |
19 | 93454 | 2.330 |
23 | 239977 | 2.320 |
13 | 82752 | 2.310 |
17 | 101305 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.350 | 28853 | 19 |
2.360 | 44298 | 26 |
2.370 | 69987 | 14 |
2.380 | 194063 | 16 |
2.390 | 197592 | 22 |
Last trade - 11.41am 23/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |